From: Clinical utility of measuring expression levels of KAP1, TIMP1 and STC2 in peripheral blood of patients with gastric cancer
Healthy volunteers
Gastric cancer
Recurrent patients
Age (range)
59 y (35 to 86 y)
60 y (36 to 87 y)
64 y (51 to 65 y)
Gender
Female
31
35
11
Male
76
77
TNM Stage
I
14
0
II
40
13
III
39
26
IV
19
3
Resection margins
R0
70
42
R1
17
R2
23